Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium
Circulation · 20.06.2023 · 147 (25) · 1933-1944
DOI: 10.1161/circulationaha.123.064473 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Circulation, erschienen am 20.06.2023. Verfasst von Davide Capodanno und 40 weiteren Autor:innen. Beteiligte Einrichtung: Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-San Marco," University of Catania, Italy (D.C., P.C.). Hauptthemen laut MEDLINE: Coronary Artery Disease, Acute Coronary Syndrome, Thrombosis, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 176-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Antiplatelet therapy is the mainstay of pharmacologic treatment to prevent thrombotic or ischemic events in patients with coronary artery disease treated with percutaneous coronary intervention and those treated medically for an acute coronary syndrome. The use of antiplatelet therapy comes at the expense of an increased risk of bleeding complications. Defining the optimal intensity of platelet inhibition according to the clinical presentation of atherosclerotic cardiovascular disease and individual patient factors is a clinical challenge. Modulation of antiplatelet therapy is a medical action that is frequently performed to balance the risk of thrombotic or ischemic events and the risk of bleeding. This aim may be achieved by reducing (ie, de-escalation) or increasing (ie, escalation) the intensity of platelet inhibition by changing the type, dose, or number of antiplatelet drugs. Because de-escalation or escalation can be achieved in different ways, with a number of emerging approaches, confusion arises with terminologies that are often used interchangeably. To address this issue, this Academic Research Consortium collaboration provides an overview and definitions of different strategies of antiplatelet therapy modulation for patients with coronary artery disease, including but not limited to those undergoing percutaneous coronary intervention, and consensus statements on standardized definitions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-San Marco," University of Catania, Italy (D.C., P.C.).
- Zena and Michael A. Wiener Cardiovascular Institute (R.M.), Icahn School of Medicine at Mount Sinai, New York, NY.
- Duke University Medical Center, Durham, NC (M.W.K., R.D.L.).
- University of Oklahoma Health Sciences Center, Oklahoma City (U.B.).
- Mount Sinai Heart (D.L.B.), Icahn School of Medicine at Mount Sinai, New York, NY.
- Sorbonne Université, ACTION Study Group, Institut de Cardiologie, Hôpital Pitié-Salpêtrière (APHP), Paris, France (J.-P.C.).
ORCID-Profile: Davide Capodanno, Roxana Mehran, Deepak L Bhatt, Giuseppe De Luca, Leonardo De Luca, Joo-Yong Hahn, Myeong-Ki Hong, Stefan James, Adnan Kastrati, Takeshi Kimura, Pedro A Lemos, Renato D Lopes, Shuichi Mochizuki, Michelle L O'Donoghue, Naveen L Pereira, Sunil V Rao, Peter C Smits, P Gabriel Steg, Robert F Storey, Jurrien Ten Berg, Marco Valgimigli, Pascal Vranckx, Hirotoshi Watanabe, Stephan Windecker, Patrick W Serruys, Robert W Yeh, Dominick J Angiolillo
Zitieren
APA
Capodanno, D., Mehran, R., Krucoff, M. W., Baber, U., Bhatt, D. L., Capranzano, P., Collet, J. P., Cuisset, T., De Luca, G., De Luca, L., Farb, A., Franchi, F., Gibson, C. M., Hahn, J. Y., Hong, M. K., James, S., Kastrati, A., Kimura, T., Lemos, P. A., …, & Angiolillo, D. J. (2023). Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium. Circulation, 147(25), 1933-1944. https://doi.org/10.1161/circulationaha.123.064473
Vancouver
Capodanno D, Mehran R, Krucoff MW, Baber U, Bhatt DL, Capranzano P, et al. Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium. Circulation. 2023;147(25):1933-1944. doi:10.1161/circulationaha.123.064473
BibTeX
@article{Capodanno2023,
author = {Capodanno, Davide and Mehran, Roxana and Krucoff, Mitchell W and Baber, Usman and Bhatt, Deepak L and Capranzano, Piera and Collet, Jean-Philippe and Cuisset, Thomas and De Luca, Giuseppe and De Luca, Leonardo and Farb, Andrew and Franchi, Francesco and Gibson, C Michael and Hahn, Joo-Yong and Hong, Myeong-Ki and James, Stefan and Kastrati, Adnan and Kimura, Takeshi and Lemos, Pedro A and Lopes, Renato D and Magee, Adrian and Matsumura, Ryosuke and Mochizuki, Shuichi and O'Donoghue, Michelle L and Pereira, Naveen L and Rao, Sunil V and Rollini, Fabiana and Shirai, Yuko and Sibbing, Dirk and Smits, Peter C and Steg, P Gabriel and Storey, Robert F and Ten Berg, Jurrien and Valgimigli, Marco and Vranckx, Pascal and Watanabe, Hirotoshi and Windecker, Stephan and Serruys, Patrick W and Yeh, Robert W and Morice, Marie-Claude and Angiolillo, Dominick J},
title = {Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium},
journal = {Circulation},
year = {2023},
volume = {147},
number = {25},
pages = {1933--1944},
doi = {10.1161/circulationaha.123.064473}
}
EUVIMED